How much of NLS pharmaceutics stock is owned by institutions?
Only 12.52% of the stock of NLS Pharmaceutics is held by institutions. Earnings for NLS Pharmaceutics are expected to grow in the coming year, from ($0.54) to ($0.29) per share. Is NLS Pharmaceutics a buy right now?
What are analysts'1-year price targets for NLS pharmaceutics'stock?
3 analysts have issued 1-year price objectives for NLS Pharmaceutics' stock. Their forecasts range from $8.00 to $12.00. On average, they expect NLS Pharmaceutics' stock price to reach $10.67 in the next twelve months. This suggests a possible upside of 1,103.9% from the stock's current price.
Where can I buy shares of NLSP?
Shares of NLSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is Nlsp a good stock to buy?
The consensus among 3 Wall Street analysts covering (NASDAQ: NLSP) stock is to Strong Buy NLSP stock.
Will Nlsp stock go up?
Based on 1 Wall Street analysts offering 12 month price targets for NLS Pharmaceutics in the last 3 months. The average price target is $12.00 with a high forecast of $12.00 and a low forecast of $12.00. The average price target represents a 2162.02% change from the last price of $0.53.
How has NLS Pharmaceutics' stock price performed in 2022?
NLS Pharmaceutics' stock was trading at $1.11 at the beginning of the year. Since then, NLSP shares have decreased by 43.2% and is now trading at $...
When is NLS Pharmaceutics' next earnings date?
NLS Pharmaceutics is scheduled to release its next quarterly earnings announcement on Thursday, June 23rd 2022. View our earnings forecast for NLS...
Who are NLS Pharmaceutics' key executives?
NLS Pharmaceutics' management team includes the following people: Mr. Alexander Zwyer M.B.A. , Pres, CEO & Director (Age 53) Mr. Subhasis Roy M....
Who are some of NLS Pharmaceutics' key competitors?
Some companies that are related to NLS Pharmaceutics include Tempest Therapeutics (TPST) , AgeX Therapeutics (AGE) , Kala Pharmaceuticals (KALA)...
When did NLS Pharmaceutics IPO?
(NLSP) raised $20 million in an initial public offering (IPO) on Friday, January 29th 2021. The company issued 3,600,000 shares at $5.00-$6.00 per...
What is NLS Pharmaceutics' stock symbol?
NLS Pharmaceutics trades on the NASDAQ under the ticker symbol "NLSP."
How do I buy shares of NLS Pharmaceutics?
Shares of NLSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is NLS Pharmaceutics' stock price today?
One share of NLSP stock can currently be purchased for approximately $0.63.
How much money does NLS Pharmaceutics make?
NLS Pharmaceutics (NASDAQ:NLSP) has a market capitalization of $7.42 million.
About NLS Pharmaceutics
Headlines
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders.
58 Biggest Movers From Yesterday
Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?
33 Stocks Moving In Thursday's Mid-Day Session
Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.
23 Stocks Moving in Thursday's Pre-Market Session
Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.
